Polymorphisms of the GCLC Gene Are Novel Genetic Markers for Susceptibility to Psoriasis Associated with Alcohol Abuse and Cigarette Smoking

The aim of this pilot study was to investigate whether single nucleotide polymorphisms (SNP) in the gene encoding the catalytic subunit of glutamate cysteine ligase (GCLC) are associated with the risk and clinical features of psoriasis. A total of 944 unrelated individuals, including 474 patients with a diagnosis of psoriasis and 470 healthy controls, were recruited for the study. Six common SNPs in the GCLC gene were genotyped using the MassArray-4 system. Polymorphisms rs648595 (OR = 0.56, 95% CI 0.35-0.90; P-perm = 0.017) and rs2397147 (OR = 0.54, 95% CI 0.30-0.98; P-perm = 0.05) were associated with susceptibility to psoriasis in males. In the male group, diplotype rs2397147-C/C x rs17883901-G/G was associated with a decreased risk of psoriasis (FDR-adjusted p = 0.014), whereas diplotype rs6933870-G/G x rs17883901-G/G (FDR-adjusted p = 0.045) showed an association with an increased disease risk in females. The joint effects of SNPs with tobacco smoking (rs648595 and rs17883901) and alcohol abuse (rs648595 and rs542914) on psoriasis risk were observed (P-perm & LE; 0.05). We also found multiple sex-independent associations between GCLC gene polymorphisms and various clinical features such as earlier disease onset, the psoriatic triad, and specific localizations of skin lesions. The present study is the first to show that polymorphisms of the GCLC gene are significantly associated with the risk of psoriasis and related to its clinical features.

Automated summary

The aim of this pilot study was to investigate the association between single nucleotide polymorphisms (SNP) in the GCLC gene and the risk and clinical features of psoriasis. A total of 944 individuals, including patients with psoriasis and healthy controls, were recruited. The study found that certain SNPs in the GCLC gene were associated with susceptibility to psoriasis, earlier disease onset, specific skin lesion localizations, and other clinical features.